GeoVax Labs, Inc. (GOVX) Form 8-K — Aug 28, 2026
GeoVax Labs received a Staff Determination Letter from Nasdaq's Listing Qualifications Department on August 27, 2026, notifying the company that Nasdaq has determined to delist its common stock from the Nasdaq Capital Market. The determination is based on the stock's closing bid price remaining below the $1.00 per share minimum required under Listing Rule 5550(a)(2) for 30 consecutive business days, from July 16, 2026 through August 26, 2026.
Key figures
- Deficiency period
- 30 consecutive business days (July 16, 2026 through August 26, 2026)
- Minimum bid price
- $1.00 per share
- Reverse split date
- January 12, 2026
- Reverse split ratio
- 1-for-25
- Denied compliance period
- 180 calendar days
- Expected suspension date
- September 8, 2026
- Hearing request deadline
- September 3, 2026
- Minimum stockholders equity requirement
- $2,500,000
Price after filing
1 day: 0.0%7 days: -33.0%30 days: -51.3%
Close on the filing date to close N calendar days later (from $0.72). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.